Generic Spiriva Inhaler (Tiova Inhaler) – Product Information
Tiova Inhaler, manufactured by Cipla Ltd. (Generic Spiriva) is a long-acting, 24 hour, anticholinergic bronchodilator which is used to for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease(COPD) which includes bronchitis and emphysema.
Generic Spiriva works by relaxing the muscles around the airways so that they open up and enables patients to breathe more easily.
The active ingredient present in Generic Spiriva Inhaler is Tiotropium Bromide.
Tiotropium Bromide Inhaler is marketed under trade names such as Spiriva and Tiova. It is also available as a dry inhalation powder under the same brand names.
Generic Spiriva Inhaler - Contraindications
Generic Spiriva Inhaler (Tiova Inhaler) is contraindicated in patients with a hypersensitivity to to Tiotropium, Ipratropium, or any inactive component of this medication.
Generic Spiriva Inhaler (Tiova Inhaler) - Dosage
Tiova Inhaler (Generic Spiriva ) comes as an inhaler with 120 metered doses in 9 mcg dosage forms.The recommended adult Oral dosage of Generic Spiriva for adults is given below:
Dosage for Treatment of Adults
The maximum dose of Tiotropium Bromide is 18 mcg (2 puffs of Tiova Inhaler) which is administered by the inhalation device.
Generic Spiriva Inhaler (Tiova Inhaler) - Warnings and Precautions
The warnings and precautions to be taken when undergoing treatment with Tiova Inhaler are given below:
- Not for emergency use: Generic Spiriva Inhaler is not for acute use, i.e., not a rescue medication
- Immediate hypersensitivity reactions: Discontinue Generic Spiriva at once and consider alternatives if immediate hypersensitivity reactions, including angioedema, bronchospasm, or anaphylaxis, occur.
- Paradoxical bronchospasm: Discontinue Generic Spiriva and consider other treatments if paradoxical bronchospasm occurs.
- Worsening of narrow-angle glaucoma may occur. Use with caution in patients with narrow-angle glaucoma and instruct patients to consult a physician immediately if this occurs.
- Worsening of urinary retention may occur. Use with caution in patients with prostatic hyperplasia or bladder-neck obstruction and instruct patient to consult a physician immediately if this occurs.
Side Effects of Generic Spiriva Inhaler (Tiova Inhaler)
The common possible side effects reported in patients treated with Tiova Inhaler (Generic Spiriva) include pharyngitis, cough, dry mouth and/or throat irritation and sinusitis . Rarely occuring side effects that occur in less than 0.1% of patients undergoing treatment are urinary retention, constipation, acute angle closure glaucoma, palpitations (notably supraventricular tachycardia and atrial fibrillation) and/or allergy (rash, angioedema, anaphylaxis).
Generic Spiriva Inhaler (Tiova Inhaler) - More Details
For more details please read the Prescription Information or watch the presentation below:
